Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR8 | Q9NR97 | 10/20 | 0.53 |
| ▸ | TLR7 | Q9NYK1 | 10/20 | 0.53 |
| ▸ | TLR9 | Q9NR96 | 9/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.41 |
| ▸ | HTR1F | P30939 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25814506 | 0.87 | TLR9 (0.44) | TLR8TLR7TLR9KDM4EPSMD14 | |
| SCHEMBL25814053 | 0.81 | TLR9 (0.46) | TLR8TLR7TLR9KDM4EPSMD14 | |
| SCHEMBL25811995 | 0.80 | KMT2A (0.49) | TLR8TLR7TLR9KDM4ESMN1; SMN2 | |
| SCHEMBL25815082 | 0.80 | TLR9 (0.46) | TLR8TLR7TLR9KDM4EPSMD14 | |
| SCHEMBL30312310 | 0.80 | TLR8 (0.52) | TLR8TLR7TLR9KDM4ESMN1; SMN2 | |
| SCHEMBL25811217 | 0.80 | TLR8 (0.52) | TLR8TLR7TLR9KDM4ESMN1; SMN2 | |
| SCHEMBL25814985 | 0.79 | TLR9 (0.52) | TLR8TLR7TLR9KDM4EPSMD14 | |
| SCHEMBL25811810 | 0.79 | TLR9 (0.48) | TLR8TLR7TLR9KDM4ESMN1; SMN2 | |
| SCHEMBL25811506 | 0.76 | KDM4E (0.67) | KDM4EPSMD14RECQLRXFP1TDP1 | |
| SCHEMBL25813827 | 0.76 | KDM4E (0.58) | TLR8TLR7TLR9KDM4EHCRTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230218573-A1 | INDOLE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | GALYAN BIO INC (US) | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230218573-A1 | INDOLE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | HTT, HYPK, PARK7 | TLR8 4582/4885TLR7 4556/4885TLR9 4628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.